A University of South Australia scientist has called for Australia to embrace pharmacogenetic (PGx) testing to deliver medication more effectively and slash around $2.4 billion wasted each year through unsafe and ineffective drug prescriptions.
The American Society of Anesthesiologists (ASA) will host PRACTICE MANAGEMENT™ 2019, Jan. 18-20, in Las Vegas. The three-day meeting will bring together leaders and subject-matter experts in anesthesia to share new research, knowledge and critical skills needed to optimize an anesthesiology practice’s performance.
John “Chip” Tilton, MD, of Case Western Reserve University School of Medicine will receive $300,000 from the Dr. Ralph and Marian Falk Medical Research Trust to develop a virus-based “nanoPOD” (nanoscale PrOtein Delivery) platform to help treat rare genetic diseases. Tilton’s project will address a major challenge in developing nanoscale therapeutics: finding ways to deliver them to the right location inside the body.
Los investigadores de Mayo Clinic junto con otros colaboradores de la Escuela de Medicina de la Universidad de Wake Forest y del Centro de Ciencias de la Salud de la Universidad de Texas en San Antonio publicaron los resultados de un ensayo clínico sobre la seguridad y la factibilidad de extraer células senescentes en un pequeño grupo de pacientes con fibrosis pulmonar.
Wistar, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc. announce the FDA has approved the initiation of a first-in-human clinical trial investigating safety and tolerability of a novel synthetic DNA-encoded monoclonal antibody (DMAb) therapeutic technology for the prevention of Zika virus infection.
An international collaboration led by scientists from the National University of Ireland, Galway, The University of St Andrews, Trinity College Dublin and the Zoological Society of London has uncovered why the venom of some snakes makes them so much deadlier than others.
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Claire M. Fraser, PhD, a pioneer in the field of microbial genomics, who is the Dean’s Endowed Professor, Department of Medicine, and Director of the Institute for Genome Sciences (IGS), has been chosen as president-elect of the American Association for the Advancement of Science (AAAS).
Researchers from the University of Southern California have discovered that a drug currently being developed to treat stroke patients could also prevent Alzheimer’s disease. The study, which will be published January 15 in the Journal of Experimental Medicine, shows that the genetically engineered protein 3K3A-APC protects the brains of mice with Alzheimer’s-like symptoms, reducing the buildup of toxic peptides and preventing memory loss.
Summaries of recent Fred Hutch research, with links for additional background and media contacts.
Pharmaceutical companies often cite R&D as the driver behind rising drug costs, but a new analysis shows that price inflation on older drugs is to blame.
The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.
Rochester, Minn. — Mayo Clinic researchers, along with collaborators from Wake Forest School of Medicine and the The University of Texas Health Sciences Center at San Antonio, have published findings from a safety and feasibility clinical trial on the removal of senescent cells from a small group of patients with pulmonary fibrosis. The findings appear in EBioMedicine.
UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human patients with drugs called senolytics. The findings were posted Jan. 4 by the journal EBioMedicine, which is published by The Lancet.
New study from Notre Dame has found that the properties of a material commonly used to create conductive or protective films and encapsulate drug compounds – and the conditions in which this material will disassemble to release that medication – may be different than initially thought.
The Henry Ford Cancer Institute announced today it has enrolled the first patient in a new clinical trial to test the effectiveness of using precise, higher dose MRI-guided radiation therapy to treat pancreatic cancer.
Suicides and drug overdoses kill American adults at twice the rate today as they did just 17 years ago, and opioids are a key contributor to that rise, according to a new review and analysis. Reversing this deadly double trend will take investment in programs that have been proven to prevent and treat opioid addiction, the researchers say.
Rutgers Robert Wood Johnson Medical School and the New Jersey Department of Health formalized a partnership that brought a member of the medical school’s faculty in as medical director of the laboratory. The lab oversees clinical diagnostic and surveillance testing; improvement service, which handles inspections and protocol compliance; and testing drinking water and groundwater, as well as handling environmental evaluations of pollutants, toxins, and heavy metals. Te director also supervises the testing of medicinal marijuana.
By pairing a novel personalized cancer vaccine with a more established immunotherapy drug that is administered to patients in an innovative fashion, scientists at Dana-Farber Cancer Institute are testing a first-of-its-kind strategy aimed at improving outcomes for kidney cancer patients who are at high risk of recurrence following surgery.
The University of Texas MD Anderson Cancer Center and Ascentage Pharma Group, Inc. today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.
Aaron S. Lord, MD, will lead a program that already has been recognized for national clinical excellence. NYU Langone Hospital–Brooklyn is one of the few hospitals in the country to hold dual certification by The Joint Commission as both a Comprehensive Stroke Center and Stroke Rehabilitation Center.
Researchers analyzed two types of interventions – lifestyle modification (exercise) and pharmacological (medicine) – to learn how best to defeat fat lying deep in the belly.
A new study published early online in Cell Chemical Biology led by Markus Seeliger, PhD, Associate Professor of Pharmacological Sciences in the Renaissance School of Medicine at Stony Brook University, takes a fresh approach to grouping kinases as potential drug targets.
In a move to maintain revenue and expand opportunities to produce and license new monoclonal antibodies, UAB has outsourced its selection of marketable monoclonal immunoreagents and hybridomas — the cells that produce monoclonal antibodies — to the Birmingham-based SouthernBiotech.
Johns Hopkins researchers have shown how to best identify nonadherent patients, combining technology with the perceptions of health care providers.
With the dawn of a new year, most Americans have just started a new health insurance coverage period -- whether they receive their coverage through a job, buy it themselves or have a government plan.
Results from a 2017 survey shared at the 2018 AANEM Annual Meeting illustrate significant disparities in the amount of training that neurology and physical medicine and rehabilitation (PMR) residents receive in electrodiagnostic (EDX) medicine.
A neurologist takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).
Study suggests that the oral medication Gabapentin can reduce pain and increase sexual desire and satisfaction
Today, the American Society of Anesthesiologists (ASA) applauded the U.S. Department of Health and Human Services (HHS) Pain Management Best Practices Interagency Task Force on the release of draft acute and chronic pain management best practice recommendations, many of which align with solutions presented and advocated by ASA.
If you’re looking for the perfect venue to share your scientific research in neuromuscular or electrodiagnostic medicine, look no further! The American Association of Neuromuscular & Electrodiagnostic Medicine is now accepting abstracts for its 2019 annual meeting in Austin, Texas.
A new Penn State Health facility gives Lancaster County residents more convenient access to primary and specialty care close to home. Penn State Health Medical Group – Lime Spring Outpatient Center, the health system’s newest, most comprehensive clinic, welcomed its first patients on Wednesday, Jan. 2.
– In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) urged the agency to proceed with caution when considering the International Pricing Index (IPI) drug pricing model, which was announced in an Advance Notice of Proposed Rulemaking in October.
It’s never too early to start thinking about end-of-life decisions. The palliative care team can help guide this discussion to learn more about the patient’s values, goals and preferences, which can help clarify these end-of-life decisions.
Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer. The funding is part of the Department of Defense’s Idea Award program, that aims to improve quality of life by decreasing the impact of cancer on active duty service members and their communities. Gupta will use the award and clinically-approved drugs to develop a safe, efficacious, and cost-effective combination therapy for castrate-resistant prostate cancer.
The Society of Toxicology (SOT) is pleased to announce the recipients of its 2019 awards. The awardees include early-career scientists to groundbreaking researchers who have impacted the field for many years.
New research from scientists at the Coriell Institute for Medical Research shows that some individuals whose bodies metabolize ibuprofen more slowly – causing the drug to be present at higher levels than intended – intuitively self-correct their dose without knowing their genetic makeup.
The often-misunderstood specialty employs low doses of radioactive materials and advanced imaging technologies to diagnose and treat a variety of diseases.
Biomedical engineer Jon Silva led an international team that determined which patients would benefit the most from a commonly used drug treatment.
La Jolla Institute for Immunology (LJI) and Kyowa Kirin Pharmaceutical Research, Inc. (KKR), a wholly-owned subsidiary of Kyowa Hakko Kirin Co., Ltd. (KHK), a global specialty pharmaceutical company, today announced the signing of a new agreement. The agreement extends the longest industry-academic collaboration in the world for another three-year term, through until the end of 2021.
Ashlee Mattingly, PharmD, BCPS, assistant professor at the University of Maryland School of Pharmacy, will collaborate with leaders of the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI).
Researchers from the University of Houston are using neutron scattering at ORNL to research how unique biological structures known as micelles can make drugs more effective. Micelles can form around drug molecules in order to transport them through the human body. To make micelles better at transporting these molecules, the researchers are investigating how micelles are affected by the molecules they transport.
Irvine, Calif., Dec. 18, 2018 — Dr. Steve Goldstein – a nationally renowned academic leader, physician and pediatric researcher – has been named vice chancellor for health affairs at the University of California, Irvine, effective Feb. 1, 2019. Goldstein will oversee and guide the development of the Susan and Henry Samueli College of Health Sciences, formed last year with a cornerstone gift of $200 million, the largest in UCI’s history.
The increasing prevalence of antibiotic resistance in the U.S. appears more closely linked with their occasional use by many people than by their repeated use among smaller numbers of people, according to a large new study from Harvard T.H. Chan School of Public Health.
After living with debilitating phantom leg pain for 18 years, Raul Silva is excited about a new dorsal root ganglion (DRG) stimulation device that erased his pain during a testing phase at UC San Diego Health, one of the only health care providers in the region offering the device.
A Wayne State University research team, in collaboration with Arterez, LLC, a Michigan-based biopharmaceutical company, has commenced a clinical study to identify the “fingerprint” and diagnostic accuracy of Arterez’ seven patent-pending glycocalyx biomarkers in relation to arterial disease, specifically hypertension and heart failure.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research describing a method to predict generic entry of top-selling drugs and a formal assessment of its accuracy.
Value in Health Regional Issues, the regionally focused online journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a series of 4 articles describing current drug policy in Estonia, Romania, Greece, and the Russian Federation.
The Keck School of Medicine of USC appoints skilled physician as chair of Department of Family Medicine
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right